E-therapeutics Plc
ETXPF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15 | -$11 | -$8 | -$11 |
| Dep. & Amort. | $1 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | -$1 | -$1 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$0 | -$0 | $0 | $0 |
| Other Non-Cash | -$2 | -$0 | $1 | -$0 |
| Operating Cash Flow | -$17 | -$11 | -$8 | -$10 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$12 |
| Inv. Sales/Matur. | $0 | $0 | $15 | $0 |
| Other Inv. Act. | -$12 | $0 | $3 | -$10 |
| Investing Cash Flow | -$12 | $0 | $18 | -$13 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | $0 | $0 |
| Stock Issued | $0 | $0 | $13 | $22 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $29 | $0 | -$0 | $8 |
| Financing Cash Flow | $29 | -$0 | $13 | $30 |
| Forex Effect | $0 | $0 | -$1 | -$9 |
| Net Chg. in Cash | -$0 | -$11 | $20 | -$3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21 | $32 | $15 | $18 |
| End Cash | $21 | $21 | $39 | $15 |
| Free Cash Flow | -$17 | -$11 | -$8 | -$12 |